Facebook Pixel

Is Endoscopist-Directed Administration of Propofol (EDP) Really Safe and Cost Efficient?

Rate This

The issue of EDP is controversial. In recent years, the use of Propofol as a form of sedation during endoscopic procedures has increased. The pharmacological effects of Propofol are favorable in comparison to the effects of opioids and benzodiazepines. Opioids are drugs which control pain and two commonly known drugs are Codeine and Morphine. Benzodiazepines are drugs which induce sedation and reduce anxiety and two commonly known drugs in this group are Versed and Valium. Generally, in the United States, Propofol is administered by an anesthesia specialist, which is defined as an anesthesiologist or a certified registered nurse anesthetist.

The controversy focuses on the debate of safety and cost efficiency. The administration of Propofol by an anesthesia specialist significantly increases the total cost of an endoscopic procedure. Anesthesiologists oppose the administration of Propofol by endoscopists claiming that it is unsafe. They cite the warning which is contained in the Propofol package insert that states that this drug should be administered only by persons who are trained in the administration of general anesthesia. It should be noted that this insert was written before evidence, which documented that nonanesthesiologists could administer Propofol safely for endoscopic procedures, was accumulated. (1)

In the October 2009 issue of Gastroenterology, an article, "Endoscopist-Directed Administration of Propofol: A Worldwide Safety Experience" by Douglas K. Rex, et al is featured. The aim of the project was to update the safety experience of EDP and the cost of using anesthesia specialists for endoscopic sedation. The researchers approached this task first by reviewing all published work involving EDP and contacting all endoscopists who they were aware of that performed EDP and obtained their safety experiences. The authors identified limitations in the study such as reliability of the data depended on the reporting of participating centers and the assumptions in cost evaluations.

The data included 646,080 identified cases.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.


Get Email Updates

Addictions Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!